AstraZeneca Starts Health-Tech Business to Add AI to Pharma

AstraZeneca Starts Health-Tech Business to Add AI to Pharma unknown

AstraZeneca Plc has formed a health-technology unit that strives to bring digital solutions and artificial intelligence to clinical trials.

The unit, dubbed Evinova, will reduce the cost and time of clinical trials, Astra saidBloomberg Terminal Monday. Parexel and Fortrea, two of the world’s biggest drug-testers, have agreed to work with Evinova.